ANO1 and leiomyosarcoma: DOG1.1 is a recently described mouse monoclonal antibody reported to have superior sensitivity and specificity compared with KIT (CD117 Small subset of mesenchymal tumors like leiomyosarcoma and synovial sarcoma also show DOG1 positivity.